Fisher Asset Management
CKPT

Fisher Asset Management’s Checkpoint Therapeutics CKPT Stock Holding History

Fisher Asset Management’s Portfolio CKPT Stock Details CKPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-1,050
Closed -$31K – 941
2021
Q2 		$31K Buy
+1,050
New +$29.1K ﹤0.01% 910

Other funds holding CKPT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JSMC
Jess S. Morgan & Co Los Angeles, California $115M AUM 16.65% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
SAG
Spotlight Asset Group Oakbrook Terrace, Illinois $143M AUM 20.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
EL
EMFO LLC Weston, Florida $112M AUM 18.79% 1-Year Est. Return

Fisher Asset Management's CKPT Position: Q3 2021 in Review

Fisher Asset Management sold out of Checkpoint Therapeutics (CKPT) in Q3 2021, closing a stake of 1,050 shares — an estimated $31K sold.

Fisher Asset Management first reported a position in CKPT in Q2 2021 and held it in 1 quarter. The position peaked at $31K in Q2 2021. 67 funds tracked by Wall St. Rank hold CKPT as of Q3 2021.

  • Fisher Asset Management reported no remaining Checkpoint Therapeutics position as of Q3 2021 after selling out during the quarter.
  • Fisher Asset Management sold 1,050 Checkpoint Therapeutics shares in Q3 2021, an estimated $31K.
  • Fisher Asset Management first reported a position in Checkpoint Therapeutics in Q2 2021 and held it in 1 quarter.
  • Fisher Asset Management's Checkpoint Therapeutics position peaked at $31K in Q2 2021.
  • 67 funds tracked by Wall St. Rank held Checkpoint Therapeutics as of Q3 2021.

Based on Fisher Asset Management's 13F filing for Q3 2021, filed 26 Oct 2021.